UK regulator greenlights Microsoft’s Inflection acquihire, but also designates it a merger

Date:

Share post:


Good news for Microsoft: The U.K.’s antitrust regulator says that the tech titan’s high-profile acquihire of the team behind AI startup Inflection doesn’t cause competition concerns, and thus it won’t be pursuing a full-scale investigation.

However, the Competition and Markets Authority (CMA) says that the deal does fall under its regulatory purview as a “relevant merger situation,” meaning similar deals in the future may still be investigated on competition grounds — even if a full acquisition has not taken place.

The ‘quasi-merger’

Microsoft launched a new consumer AI division back in March, spearheaded by the founders of Inflection which included Google DeepMind co-founder Mustafa Suleyman. CEO Satya Nadella confirmed that a number of other Inflection AI members had joined Microsoft’s new AI unit, such as AI scientist Jordan Hoffmann who is now heading up Microsoft’s U.K. AI hub in London.

Back in July, CMA revealed that it was launching a “phase 1” merger inquiry into the deal, kickstarting an investigation to gather evidence and decide whether to proceed with a full probe. Central to the initial phase was whether the deal could in fact be investigated as a “merger,” given that Microsoft hadn’t actually acquired Inflection AI. And if it does qualify as a merger, whether further action is required to counter competition concerns.

At the heart of all this is a growing push by big tech companies to circumvent regulatory scrutiny around AI, powered by a new M&A approach some have dubbed the “quasi-merger” — this could involve anything from strategic investments, to — as we’ve seen with Microsoft and Inflection — hiring startup founders and technical talent.

This is a developing story, refresh for updates



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Sony’s CES 2025 press conference: How to watch

Sony knows how to put on a show at CES. The company’s pressers are high octane, star-studded...

OpenAI ‘considered’ building a humanoid robot: Report

OpenAI has recently explored building its own humanoid robot, according to The Information. The report cites “two...

Samsung’s CES 2025 press conference: How to watch

Samsung’s CES presser is always an odd duck. The Korean electronics giant generally keeps its powder dry...

Watch Boston Dynamics’ electric Atlas do a backflip

A little early holiday surprise from Boston Dynamics this week, as Santa suit-wearing electric Atlas performs a...

Shuttered electric air taxi startup Lilium may be saved after all

A consortium of investors has resurrected Lilium just days after the electric air taxi startup ceased operations...

These are the cybersecurity stories we were jealous of in 2024

Since 2018, along with colleagues first at VICE Motherboard, and now at TechCrunch, I have been publishing...

Proton’s device aims to help those with kidney disease, and cut heart failure risks

People with chronic kidney disease, or those at risk of heart failure, are greatly affected by potassium...

Halide’s next version will come with new film filters, HDR

Lux, which makes the iPhone camera app Halide, published a roadmap on Monday detailing the app’s next...